Andrei Thomas-Tikhonenko

29PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Aug 27, 2026
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy.

|Mar 30, 2026
Alternative splicing in pediatric central nervous system tumors highlights oncofetal candidate CLK1 exon 4.

Ammar S Naqvi, Patricia J Sullivan, Ryan J Corbett

|Feb 06, 2026
The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Mar 17, 2025
The costimulatory domain influences CD19 CAR-T cell resistance development in B-cell malignancies.

Marta Krawczyk, Narcis Fernandez-Fuentes, Klaudyna Fidyt

|Jan 27, 2025
NRCAM variant defined by microexon skipping is a targetable cell surface proteoform in high-grade gliomas.

Priyanka Sehgal, Ammar S Naqvi, Makenna Higgins

|Oct 09, 2024
Steering research on mRNA splicing in cancer towards clinical translation.

Olga Anczukow, Frédéric H-T Allain, Brittany L Angarola

Pageof 5

Frequent Collaborators

13 joint publications

Katharina Hayer

10 joint publications

Yoseph Barash

8 joint publications

Manuel Torres-Diz

6 joint publications

Zhiwei Ang